FOLD - Company ID 0001178879
AMICUS THERAPEUTICS, INC. (FOLD) reported revenue of $634.21M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $634.21M | +20.0% |
| FY 2024 | $528.29M | +32.3% |
| FY 2023 | $399.36M | +21.3% |
| FY 2022 | $329.23M | +7.8% |
| FY 2021 | $305.51M | +17.1% |
| FY 2020 | $260.89M | +43.2% |
| FY 2019 | $182.24M | +99.7% |
| FY 2018 | $91.25M | +147.1% |
| FY 2017 |
AMICUS THERAPEUTICS, INC. (FOLD) reported revenue of $634.21M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2010 and fiscal 2025, AMICUS THERAPEUTICS, INC.'s revenue grew from $922.00K to $634.21M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $36.93M |
| +644.9% |
| FY 2016 | $4.96M | +305.1% |
| FY 2014 | $1.22M | +237.2% |
| FY 2013 | $363.00K | -98.0% |
| FY 2012 | $18.41M | -14.1% |
| FY 2011 | $21.43M | +2224.7% |
| FY 2010 | $922.00K | - |